< Back to previous page
Researcher
Djalila Mekahli
- Disciplines:Urology and nephrology
Affiliations
- PKD Research Group (Division)
Responsible
From1 Oct 2022 → Today - PKD Research Group (Division)
Member
From1 Oct 2022 → Today - Woman and Child (Division)
Member
From1 Oct 2013 → Today - Laboratory of Molecular and Cellular Signaling (Division)
Member
From1 Jan 2009 → 30 Sep 2013
Projects
1 - 10 of 17
- Targeting TRP channels to relief painFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Exploring the apelinergic system in autosomal dominant polycystic kidney diseaseFrom16 Jun 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Exploring the apelinergic system in autosomal dominant polycystic kidney diseaseFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Translational research into early stages of Autosomal Dominant Polycystic Kidney Disease (ADPKD)From1 Oct 2022 → TodayFunding: FWO fundamental clinical research fellowship
- TRP - Tackling the Roots of PainFrom1 Oct 2021 → TodayFunding: Fund Recuperation Fiscal Exemption, BOF - projects
- Automated slide scanner for digitalizing histopathologyFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Cytopenia and Autosomal Dominant Polycystic Kidney Disease (ADPKD)From1 Nov 2020 → TodayFunding: FWO fellowships
- A kinetic, high-throughput cellular screening system (Plate Imaging Reader) for the "real time" monitoring of dynamic intracellular Ca2+ signals in living cellsFrom1 May 2020 → TodayFunding: BOF - scientific equipment program
- Ca2+ signalling in ADPKD: mechanisms and consequences.From1 Jan 2020 → 31 Dec 2023Funding: FWO research project (including WEAVE projects)
- Translational characterization of cellular and tissular metabolic perturbations in autosomal dominant polycystic kidney diseaseFrom1 Nov 2019 → 1 Jun 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
11 - 20 of 143
- Clinical Characteristics and Courses of Patients With Autosomal Recessive Polycystic Kidney Disease-Mimicking Phenocopies(2023)
Authors: Djalila Mekahli
Pages: 1449 - 1454 - PHASE 3 TRIAL OF TOLVAPTAN IN PEDIATRIC AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): TWO YEARS OF DATA FROM AN OPEN-LABEL EXTENSION(2023)
Authors: Djalila Mekahli
Pages: I644 - I646 - RAPIDLY PROGRESSIVE AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE : RISK FACTORS FOR DISEASE SEVERITY DURING CHILDHOOD AND EARLY ADULTHOOD(2023)
Authors: Bert Bammens, Djalila Mekahli
Pages: I9 - I9 - Risk Severity Model for Pediatric Autosomal Dominant Polycystic Kidney Disease Using 3D Ultrasound Volumetry(2023)
Authors: Frederik De Keyzer, Rudi Vennekens, Bert Bammens, Chantal Van Ongeval, Djalila Mekahli
Pages: 581 - 591 - Cystic kidney diseases in children(2023)
Authors: Djalila Mekahli
Pages: 240 - 246 - Iatrogenic Cushing syndrome in a child due to erroneous compounding of omeprazole containing glucocorticoid: A case report and literature review(2023)
Authors: Francis de Zegher, Djalila Mekahli, Kristina Casteels
Pages: 247 - 250 - Autosomal Dominant Polycystic Kidney Disease in Children and Adolescents: Assessing and Managing Risk of Progression(2023)
Authors: Liselotte Van Loo, Djalila Mekahli
Pages: 236 - 244 - Long-term outcomes of acute kidney injury in children(2023)
Authors: Djalila Mekahli, Dirk Vlasselaers
Pages: 259 - 267 - DISEASE BURDEN AND DISEASE PROGRESSION OF YOUNG ADULT PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE(2023)
Authors: Djalila Mekahli
Pages: S102 - S102 - Polycystic Kidney Disease Drug Development: A Conference Report(2023)
Authors: Djalila Mekahli